| Authors: |
Raoof S; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Mulford IJ; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Frisco-Cabanos H; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Nangia V; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Timonina D; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Labrot E; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Hafeez N; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Bilton SJ; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Drier Y; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Ji F; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Greenberg M; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Williams A; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Kattermann K; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Damon L; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA., Sovath S; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Rakiec DP; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Korn JM; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Ruddy DA; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Benes CH; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Hammerman PS; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Piotrowska Z; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Sequist LV; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Niederst MJ; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Barretina J; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Engelman JA; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Hata AN; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, MA, USA. ahata@mgh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. ahata@mgh.harvard.edu. |
